Repligen
RGEN
#2039
Rank
A$14.10 B
Marketcap
A$250.53
Share price
-0.46%
Change (1 day)
8.10%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$37.75 Million

According to Repligen 's latest financial reports the company's current earnings are A$0.70 Billion. In 2024 the company made an earning of -A$9.53 Million a decrease over its 2023 earnings that were of A$73.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$37.75 M-496.22%
2024 -A$9.53 Million-113.01%
2023 A$73.22 M-78.01%
2022 A$0.33 B33.37%
2021 A$0.24 B131.52%
2020 A$0.10 B101.31%
2019 A$53.56 M25.93%
2018 A$42.53 M105.61%
2017 A$20.68 M-11.46%
2016 A$23.36 M14.91%
2015 A$20.33 M20.26%
2014 A$16.91 M-51.49%
2013 A$34.85 M90.98%
2012 A$18.25 M
2010 A$0.26 M-103.81%
2009 -A$6.94 Million-223.84%
2008 A$5.59 M
2006 -A$3.77 Million229.64%
2005 -A$1.15 Million-89.16%
2004 -A$10.53 Million-16.86%
2003 -A$12.67 Million88.72%
2002 -A$6.71 Million-27.88%
2001 -A$9.31 Million-1.74%
2000 -A$9.47 Million85.93%
1999 -A$5.1 Million159.16%
1998 -A$1.97 Million85.71%
1997 -A$1.06 Million-70.83%
1996 -A$3.63 Million-72.41%
1995 -A$13.15 Million-60.63%
1994 -A$33.41 Million45.39%
1993 -A$22.98 Million39.45%
1992 -A$16.48 Million-32.3%
1991 -A$24.34 Million6.62%
1990 -A$22.83 Million1577.78%
1989 -A$1.37 Million-57.14%
1988 -A$3.18 Million-362.5%
1987 A$1.2 M-130.77%
1986 -A$3.93 Million136.36%
1985 -A$1.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
A$0.56 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.02 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.88 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.50 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.72 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.14 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.91 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$33.55 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA